These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21314231)

  • 1. Neurobiological aspects of Alzheimer's disease.
    Chopra K; Misra S; Kuhad A
    Expert Opin Ther Targets; 2011 May; 15(5):535-55. PubMed ID: 21314231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives on pharmacotherapy of Alzheimer's disease.
    Chopra K; Misra S; Kuhad A
    Expert Opin Pharmacother; 2011 Feb; 12(3):335-50. PubMed ID: 21222549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
    Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
    Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease].
    Abe K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutics of Alzheimer's disease: Past, present and future.
    Anand R; Gill KD; Mahdi AA
    Neuropharmacology; 2014 Jan; 76 Pt A():27-50. PubMed ID: 23891641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: a general introduction and pathomechanism.
    Finder VH
    J Alzheimers Dis; 2010; 22 Suppl 3():5-19. PubMed ID: 20858960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR
    J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-based therapy in Alzheimer's disease.
    Pul R; Dodel R; Stangel M
    Expert Opin Biol Ther; 2011 Mar; 11(3):343-57. PubMed ID: 21261567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel insights for the treatment of Alzheimer's disease.
    Kurz A; Perneczky R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):373-9. PubMed ID: 20655969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The revitalized tau hypothesis on Alzheimer's disease.
    Maccioni RB; Farías G; Morales I; Navarrete L
    Arch Med Res; 2010 Apr; 41(3):226-31. PubMed ID: 20682182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
    Castellani RJ; Zhu X; Lee HG; Moreira PI; Perry G; Smith MA
    Expert Rev Neurother; 2007 May; 7(5):473-85. PubMed ID: 17492899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond amyloid: the future of therapeutics for Alzheimer's disease.
    Lane RF; Shineman DW; Steele JW; Lee LB; Fillit HM
    Adv Pharmacol; 2012; 64():213-71. PubMed ID: 22840749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of drugs for Alzheimer's disease.
    Sun X; Jin L; Ling P
    Drug Discov Ther; 2012 Dec; 6(6):285-90. PubMed ID: 23337815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viewpoint: Crosstalks between neurofibrillary tangles and amyloid plaque formation.
    Luan K; Rosales JL; Lee KY
    Ageing Res Rev; 2013 Jan; 12(1):174-81. PubMed ID: 22728532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs targeting Alzheimer's disease: some things old and some things new.
    Michaelis ML
    J Pharmacol Exp Ther; 2003 Mar; 304(3):897-904. PubMed ID: 12604663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.